DOI:
10.1055/s-00000069
Seminars in Liver Disease
LinksClose Window
References
Mullard A.
FDA rejects NASH drug.
Nat Rev Drug Discov 2020;
19 (08) 501
We do not assume any responsibility for the contents of the web pages of other providers.